Clinical Research

Results of multiple clinical studies have demonstrated that VAX-D is an effective treatment for the management of chronic low back pain. A retrospective outcome study on 778 patients, a Phase II Randomized Controlled Trial (Australia) and a study conducted in a neurosurgery practice on 142 patients all reported approximately 70% success rates and improvements in functional outcomes for patients suffering from disc related chronic low back pain.

In addition, several research articles have been published examining the mechanism of action of VAX-D. Studies on the effects of VAX-D on intradiscal pressures have been reported, and it’s effects on sensory nerve dysfunction in patients with low back pain and radiculopathy have been reported.

Dermatomal Somatosensory Evoked Potentials (DSSEP’s) were used to demonstrate lumbar nerve root decompression following VAX-D Therapy.

VAX-D Medical Technologies has been at the forefront of research in spinal pain (low back and cervical pathology).

VAX-D has had a long history of peer reviewed clinical studies published on different aspects of the Therapy. The VAX-D system is being utilized and studied by leading physicians in Orthopaedic Medicine, Pain Management, Anesthesiology, Occupational Medicine and Rehabilitation, Neurology, Neurosurgery and Family Practice. Research on the therapy is ongoing and VAX-D Medical Technologies will post future publications on this website as they become available.